Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: McNeil Consumer Products

This article was originally published in The Tan Sheet

Executive Summary

McNeil Consumer Products: Firm supports three-year marketing exclusivity for SmithKline Beecham's recently approved Nicorette and Nicorette DS smoking cessation gum in comments filed with FDA on Feb. 9. The comments oppose a Nov. 2 citizen petition urging that Nicorette not be granted exclusivity, filed by McKenna & Cuneo on behalf of an unnamed client ("The Tan Sheet" Nov. 20, 1995, p. 2). McNeil says, "To deny exclusivity in such instances, and permit introduction of generic copies immediately upon approval of such OTC switch products, would have a chilling effect on innovation in the OTC industry and, thus, should not be permitted"...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS084866

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel